Research / CRUS / Fundamental state Inspectable configuration
State dimensions Filing 0000772406-26-000037 General Corporate
Capex intensity 90th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
3.29% · OPTIONAL · VALID
Operating cash generation 40th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
13.95% · OPTIONAL · VALID
Revenue growth 70th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
12.88% · CORE · VALID
Inventory pressure 75th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
57.15% · OPTIONAL · VALID
Gross margin 80th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
52.61% · CORE · VALID
Operating margin 30th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
18.37% · CORE · VALID
R&D intensity 75th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
25.02% · OPTIONAL · VALID
SBC intensity 70th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
4.48% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 53 states Self-history eligible
Sep 25, 2021 8/8 normalized Level 3 Dec 25, 2021 8/8 normalized Level 3 Mar 26, 2022 8/8 normalized Level 3 Jun 25, 2022 8/8 normalized Level 3 Sep 24, 2022 8/8 normalized Level 3 Dec 24, 2022 8/8 normalized Level 3 Mar 25, 2023 8/8 normalized Level 3 Jun 24, 2023 8/8 normalized Level 3 Sep 23, 2023 8/8 normalized Level 3 Dec 30, 2023 8/8 normalized Level 3 Mar 30, 2024 8/8 normalized Level 3 Jun 29, 2024 8/8 normalized Level 3 Sep 28, 2024 8/8 normalized Level 3 Dec 28, 2024 8/8 normalized Level 3 Mar 29, 2025 8/8 normalized Level 3 Jun 28, 2025 8/8 normalized Level 3 Sep 27, 2025 8/8 normalized Level 3 Dec 27, 2025 8/8 normalized Level 3 Mar 28, 2026 8/8 normalized Level 3 Jun 27, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Capex Intensity Increased
Previous 0.70%
Current 3.29%
Delta 2.59% Cash Generation Decreased
Previous 32.57%
Current 13.95%
Delta -18.62% Growth Increased
Previous 5.34%
Current 12.88%
Delta 7.54% Inventory Pressure Increased
Previous 12.06%
Current 57.15%
Delta 45.09% Margin Decreased
Previous 52.78%
Current 52.61%
Delta -0.17% Profitability Decreased
Previous 23.05%
Current 18.37%
Delta -4.68% R And D Intensity Increased
Previous 21.73%
Current 25.02%
Delta 3.29% Sbc Intensity Increased
Previous 4.10%
Current 4.48%
Delta 0.38% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Jun 25, 2022
Similarity 81%
Compared 8 dimensions
Coverage 100% Growth 30.0 · Margin 25.0 · Profitability 5.0 · Sbc Intensity 10.0 · Capex Intensity 30.0 · Cash Generation 5.0 · R And D Intensity 0.0 · Inventory Pressure 15.0 Jun 24, 2017
Similarity 79%
Compared 7 dimensions
Coverage 88% Growth 36.7 · Margin 7.5 · Profitability 1.3 · Sbc Intensity 1.3 · Capex Intensity 33.8 · R And D Intensity 12.5 · Inventory Pressure 18.8 Jun 26, 2021
Similarity 78%
Compared 8 dimensions
Coverage 100% Growth 0.0 · Margin 25.0 · Profitability 20.0 · Sbc Intensity 25.0 · Capex Intensity 5.0 · Cash Generation 40.0 · R And D Intensity 5.0 · Inventory Pressure 20.0 Jun 29, 2024
Similarity 76%
Compared 8 dimensions
Coverage 100% Growth 10.0 · Margin 55.0 · Profitability 10.0 · Sbc Intensity 25.0 · Capex Intensity 0.0 · Cash Generation 25.0 · R And D Intensity 5.0 · Inventory Pressure 5.0 Mar 31, 2018
Similarity 73%
Compared 7 dimensions
Coverage 88% Growth 43.3 · Margin 6.3 · Profitability 12.1 · Sbc Intensity 12.1 · Capex Intensity 5.8 · R And D Intensity 9.2 · Inventory Pressure 53.9 Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.